EUVIMEDEUVIMED entdecken
Multizentrische Studie

Catheter ablation of atrial fibrillation in patients with heart failure: Insights from the NCDR atrial fibrillation ablation registry

Omair Yousuf, Joseph Akar, Zhen Tan, Mutaz Alkalbani, Hameeda Tasneem, Benjamin A Steinberg, Jonathan C Hsu, Brett Atwater, Eunice Yang, John Spertus, Hugh Calkins, James V Freeman

Heart Rhythm · 2026

DOI: 10.1016/j.hrthm.2025.06.048 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Heart Rhythm, 2026. Verfasst von Omair Yousuf und 11 weiteren Autor:innen. Beteiligte Einrichtung: Divsion of Cardiac Electrophysiology, Virginia Hospital Center, Arlington, Virginia; Pulse Point, Fairfax, Virginia; Department of Cardiovascular Med…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Registries, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: NHLBI NIH HHS, American College of Cardiology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Catheter ablation (CA) for atrial fibrillation (AF) is a widely used treatment strategy in patients with and without heart failure (HF). OBJECTIVE: To evaluate patient characteristics, ablation strategies, and complications of CA for AF by HF status. METHODS: We conducted a retrospective analysis of patients undergoing CA between 2016 and 2022 from the National Cardiovascular Data Registry. Patients were grouped by: HF with reduced ejection fraction (HFrEF), HF with preserved EF (HFpEF), and no HF. Multivariable logistic regression was used to assess complication risk. RESULTS: Among 75,527 patients, 51,285 had no HF, 13,625 had HFrEF, and 10,617 had HFpEF. HF groups had a higher prevalence of hypertension, diabetes, and coronary disease. Patients with HFrEF received more adjunctive ablation than patients HFpEF or no HF, including linear (32%, 29.3%, and 23.4%, respectively) and cavotricuspid isthmus ablation (33.1%, 30.2%, and 30.1%, respectively) (P < .0001). Complication rates were higher in HFrEF (4%) and HFpEF (3.8%) vs no HF (2%), with adjusted odds ratios (HFrEF: OR, 1.80; P < .0001; HFpEF: OR, 1.42; P < .0001). Complication rates declined from 2016 to 2022 across all groups (HFrEF: 5.2% to 2.9%, P = .0002; HFpEF: 5.9% to 3.0%, P < .0001; no HF: 2.8% to 1.6%, P < .0001). Ablation volume increased from 2018 to 2022 by 138% (HFrEF), 191% (HFpEF), and 113% (no HF). CONCLUSION: Patients with HFrEF and HFpEF have more comorbidities, undergo more adjunctive ablation, and experience higher complication rates. Despite this, ablation volumes rose and complications declined across all groups over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationRegistriesHeart FailureStroke VolumePostoperative ComplicationsHumansMaleFemaleRetrospective StudiesAgedMiddle AgedTreatment OutcomeUnited StatesFollow-Up StudiesRisk Factors

Stichwörter der Autor:innen

Atrial fibrillationCatheter ablationHFpEFHFrEFHeart failureNCDR

Autor:innen und Institutionen

  • Divsion of Cardiac Electrophysiology, Virginia Hospital Center, Arlington, Virginia; Pulse Point, Fairfax, Virginia; Department of Cardiovascular Medicine, Saint Luke's Hospital, Mid America Heart Institute, Kansas City…
  • Center for Outcomes Research and Evaluation, Yale New Haven Health, Yale University School of Medicine, New Haven, Connecticut.
  • Inova Health System, Fairfax, Virginia.
  • Carient Heart and Vascular, Manassas, Virginia.
  • Denver Health Medical Center, Denver, Colorado; Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aroura, Colorado; CPC Clinical Research, Aurora, Colorado.
  • Division of Cardiovascular Medicine, University of California San Diego, San Diego, California.

Förderung

  • NHLBI NIH HHS
  • American College of Cardiology Foundation

Zitieren

APA

Yousuf, O., Akar, J., Tan, Z., Alkalbani, M., Tasneem, H., Steinberg, B. A., Hsu, J. C., Atwater, B., Yang, E., Spertus, J., Calkins, H., & Freeman, J. V. (2026). Catheter ablation of atrial fibrillation in patients with heart failure: Insights from the NCDR atrial fibrillation ablation registry. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2025.06.048

Vancouver

Yousuf O, Akar J, Tan Z, Alkalbani M, Tasneem H, Steinberg BA, et al. Catheter ablation of atrial fibrillation in patients with heart failure: Insights from the NCDR atrial fibrillation ablation registry. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2025.06.048

BibTeX
@article{Yousuf2026,
  author = {Yousuf, Omair and Akar, Joseph and Tan, Zhen and Alkalbani, Mutaz and Tasneem, Hameeda and Steinberg, Benjamin A and Hsu, Jonathan C and Atwater, Brett and Yang, Eunice and Spertus, John and Calkins, Hugh and Freeman, James V},
  title = {Catheter ablation of atrial fibrillation in patients with heart failure: Insights from the NCDR atrial fibrillation ablation registry},
  journal = {Heart Rhythm},
  year = {2026},
  doi = {10.1016/j.hrthm.2025.06.048}
}
Kostenlos starten →